{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:56:18Z","timestamp":1790362578378,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012196","name":"James and Debbie Cho Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21 NS103820"],"award-info":[{"award-number":["R21 NS103820"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS074926"],"award-info":[{"award-number":["U01 NS074926"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["I01 BX000273-07"],"award-info":[{"award-number":["I01 BX000273-07"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neuropharm.2020.108444","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:13:18Z","timestamp":1610032398000},"page":"108444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors"],"prefix":"10.1016","volume":"185","author":[{"given":"Lucille","family":"Lumley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Niquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Marrero-Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"de Araujo Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2020.108444_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15376516.2016.1197992","article-title":"Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats","volume":"26","author":"Acon-Chen","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.neuropharm.2020.108444_bib99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13028","article-title":"Long-term neuropathological and behavioral impairments after exposure to nerve agents","volume":"1374","author":"Aroniadou-Anderjaska","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108444_bib3","first-page":"221","article-title":"Neuroprotection as a Treatment. In Medical aspects of chemical warfare","author":"Ballough","year":"2008"},{"key":"10.1016\/j.neuropharm.2020.108444_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuro.2015.07.003","article-title":"Beneficial effects of a ketamine\/atropine combination in soman-poisoned rats under a neutral thermal environment","volume":"50","author":"Barbier","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2020.108444_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108444_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0272-0590(81)80020-6","article-title":"Differences in the toxicity of soman in various strains of mice","volume":"1","author":"Clement","year":"1981","journal-title":"Fund. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108444_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbadis.2017.02.003","article-title":"Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy","volume":"1863","author":"Clossen","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108444_bib10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"de Araujo Furtado","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneumeth.2009.07.020","article-title":"Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study","volume":"184","author":"de Araujo Furtado","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.taap.2011.12.024","article-title":"Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice","volume":"259","author":"Dhote","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2020.108444_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tox.2007.05.032","article-title":"Prolonged inflammatory gene response following soman-induced seizures in mice","volume":"238","author":"Dhote","year":"2007","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tox.2007.02.012","article-title":"Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in Guinea-pigs","volume":"234","author":"Dorandeu","year":"2007","journal-title":"Toxicology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2020.108444_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.06.013","article-title":"Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus","volume":"1051","author":"Dorandeu","year":"2005","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108444_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cns.12096","article-title":"Treatment of status epilepticus with ketamine, are we there yet?","volume":"19","author":"Dorandeu","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib19","first-page":"57","article-title":"Inhibition by ketamine of muscarinic acetylcholine receptor function","volume":"81","author":"Durieux","year":"1995","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbi.2011.12.006","volume":"195","author":"Duysen","year":"2012","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.neuropharm.2020.108444_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/qjmed\/93.11.715","article-title":"Patterns and problems of deliberate self-poisoning in the developing world","volume":"93","author":"Eddleston","year":"2000","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0149-7634(05)80101-0","article-title":"Stagewise, adaptive dose allocation for quantal response dose-response studies","volume":"15","author":"Feder","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2020.108444_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/epi.14500","article-title":"Acute and long-term consequences of exposure to organophosphate nerve agents in humans","volume":"59","author":"Figueiredo","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00000542-200009000-00032","article-title":"Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells","volume":"93","author":"Friederich","year":"2000","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108444_bib26","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108444_bib27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1528-1157.2003.62402.x","article-title":"Diazepam terminates brief but not prolonged seizures in young, naive rats","volume":"44","author":"Goodkin","year":"2003","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.taap.2007.11.006","article-title":"Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits","volume":"227","author":"Grauer","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108444_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2458-7-357","article-title":"The global distribution of fatal pesticide self-poisoning: systematic review","volume":"7","author":"Gunnell","year":"2007","journal-title":"BMC Publ. Health"},{"issue":"20","key":"10.1016\/j.neuropharm.2020.108444_bib30","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.5443-07.2008","article-title":"Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits","volume":"28","author":"Hevers","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.24986","article-title":"Timing is everything: where status epilepticus treatment fails","volume":"82","author":"Hill","year":"2017","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells7040026","article-title":"Microglia after seizures and in epilepsy","volume":"7","author":"Hiragi","year":"2018","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108444_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408444.2020.1787330","article-title":"A national toxicology program systematic review of the evidence for long-term effects after acute exposure to sarin nerve agent","volume":"50","author":"Jett","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0920-1211(90)90025-Q","article-title":"NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures","volume":"5","author":"Kapur","year":"1990","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/jn.1989.61.2.417","article-title":"Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition","volume":"61","author":"Kapur","year":"1989","journal-title":"J. Neurophysiol."},{"issue":"22","key":"10.1016\/j.neuropharm.2020.108444_bib36","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-4274(85)90212-7","article-title":"Comparison of known sodium-channel blockers in DFP toxicity","volume":"25","author":"Klemm","year":"1985","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2020.108444_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.14311","article-title":"Delayed midazolam dose effects against soman in male and female plasma carboxylesterase knockout mice","author":"Kundrick","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pbb.2011.09.011","article-title":"Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: increased startle reactivity and perseverative behavior","volume":"100","author":"Langston","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108444_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuro.2018.08.011","article-title":"Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes","volume":"69","author":"Lewine","year":"2018","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108444_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0013-4694(72)90065-X","article-title":"Effect of diazepam upon soman-induced seizure activity and convulsions","volume":"32","author":"Lipp","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108444_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2012.07.046","article-title":"Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats","volume":"1474","author":"Loss","year":"2012","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2020.108444_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2015.193","article-title":"Decade in review-epilepsy: edging toward breakthroughs in epilepsy diagnostics and care","volume":"11","author":"Lowenstein","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108444_bib44","doi-asserted-by":"crossref","first-page":"104629","DOI":"10.1016\/j.dib.2019.104629","article-title":"Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats","volume":"27","author":"Lumley","year":"2019","journal-title":"Data Brief"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/epi4.12344","article-title":"Neurosteroid and benzodiazepine combination therapy reduces status epilepticus and long\u2010term effects of whole\u2010body sarin exposure in rats","volume":"4","author":"Lumley","year":"2019","journal-title":"Epilepsia open"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-018-2235-2","article-title":"Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus","volume":"22","author":"Madzar","year":"2018","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.neuropharm.2020.108444_bib47","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/epi.14582","article-title":"Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam","volume":"59","author":"Marrero-Rosado","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2020.108444_bib48","doi-asserted-by":"crossref","first-page":"107229","DOI":"10.1016\/j.yebeh.2020.107229","article-title":"Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice","volume":"111","author":"Marrero-Rosado","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-4274(87)90254-2","article-title":"The effect of carboxylesterase inhibition on interspecies differences in soman toxicity","volume":"39","author":"Maxwell","year":"1987","journal-title":"Toxicol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2020.108444_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2020.108444_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(98)00606-4","article-title":"Self-sustaining status epilepticus after brief electrical stimulation of the perforant path","volume":"801","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of soman-induced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib55","first-page":"123","article-title":"Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment","volume":"16","author":"McDonough","year":"1995","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib56","first-page":"381","article-title":"Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman","volume":"19","author":"McDonough","year":"1998","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(99)00060-1","article-title":"Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated Guinea pigs","volume":"38","author":"McDonough","year":"2000","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2010.11.022","article-title":"Impaired auditory and contextual fear conditioning in soman-exposed rats","volume":"98","author":"Moffett","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-4886(87)90293-7","article-title":"Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats","volume":"97","author":"Morrisett","year":"1987","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108444_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108444_bib100","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.neuropharm.2020.108444_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"34","key":"10.1016\/j.neuropharm.2020.108444_bib62","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2020.108444_bib63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1167.2005.01022.x","article-title":"GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation","volume":"46","author":"Naylor","year":"2005","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/CPJ.0000000000000641","article-title":"Therapy for acute nerve agent poisoning: an update","volume":"9","author":"Newmark","year":"2019","journal-title":"Neurol Clin Pract"},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108444_bib65","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib66","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2020.108444_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2020.108444_bib68","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.yebeh.2019.06.011","article-title":"Early polytherapy for benzodiazepine-refractory status epilepticus","volume":"101","author":"Niquet","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2020.108444_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-1211(99)00088-1","article-title":"A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat","volume":"38","author":"Nissinen","year":"2000","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hipo.1044","article-title":"Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?","volume":"11","author":"Nissinen","year":"2001","journal-title":"Hippocampus"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0272-0590(81)80065-6","article-title":"Soman neurotoxicity","volume":"1","author":"Petras","year":"1981","journal-title":"Fund. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(92)90019-C","article-title":"Behavioral performance, brain histology, and EEG sequela after immediate combined atropine\/diazepam treatment of soman-intoxicated rats","volume":"42","author":"Philippens","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108444_bib73","article-title":"Anticonvulsant therapy for status epilepticus","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108444_bib75","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108444_bib77","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib78","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.neuro.2012.02.010","article-title":"Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure","volume":"33","author":"Rossetti","year":"2012","journal-title":"Neurotoxilcology"},{"key":"10.1016\/j.neuropharm.2020.108444_bib79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.seizure.2018.08.002","article-title":"Pathophysiology of convulsive status epilepticus","volume":"68","author":"Sanchez Fernandez","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2020.108444_bib80","series-title":"Evaluation of Multifunctional Compounds Possessing Anticholinergic and Antiglutamatergic Properties for Efficacy against Soman Toxicity in Rats","author":"Schultz","year":"2015"},{"key":"10.1016\/j.neuropharm.2020.108444_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108444_bib82","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.taap.2012.01.017","article-title":"The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam","volume":"259","author":"Schultz","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib83","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4274(91)90128-S","article-title":"A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning","volume":"55","author":"Shih","year":"1991","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108444_bib86","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2020.108444_bib87","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/epi.12284","article-title":"Lessons from the RAMPART study \u2013 and which is the best route of administration of benzodiazepines in status epilepticus","volume":"54","author":"Silbergleit","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2020.108444_bib88","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108444_bib89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1197\/j.aem.2005.10.018","article-title":"Multiple centrally acting antidotes protect against severe organophosphate toxicity","volume":"13","author":"Sivilotti","year":"2006","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2020.108444_bib90","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-2094-8-84","article-title":"Transcriptional responses of the nerve agent-sensitive brain regions amygdala, hippocampus, piriform cortex, septum, and thalamus following exposure to the organophosphonate anticholinesterase sarin","volume":"8","author":"Spradling","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1203\/01.pdr.0000196333.16608.30","article-title":"Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects","volume":"59","author":"Suchomelova","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108444_bib92","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108444_bib93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0736-4679(98)00170-X","article-title":"Use of intramuscular midazolam for status epilepticus","volume":"17","author":"Towne","year":"1999","journal-title":"J. Emerg. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2020.108444_bib94","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2020.108444_bib95","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2019.10.009","article-title":"Effects of diazepam and ketamine on pilocarpine-induced status epilepticus in mice","volume":"421","author":"Wang","year":"2019","journal-title":"Neuroscience"},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2020.108444_bib96","first-page":"S134","article-title":"Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators","volume":"41","author":"Wasterlain","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2020.108444_bib97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxlet.2015.11.023","article-title":"Comparison of the lethal effects of chemical warfare nerve agents across multiple ages","volume":"241","author":"Wright","year":"2016","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108444_bib98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(92)90248-3","article-title":"Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons","volume":"213","author":"Zeilhofer","year":"1992","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820305128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820305128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:36:13Z","timestamp":1777426573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820305128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":100,"alternative-id":["S0028390820305128"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108444","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108444"}}